Thus, our model for the first time successfully integrates conflicting findings on DMD's oncogenic versus tumour‐suppressive behaviours, demonstrating that DMD behaves as a tumour suppressor in more characteristically metastatic (i.e. aggressive) cancers but exhibits oncogenic properties in less aggressive, locally invasive tumours (Fig. 7 and Table 1). The gene discussed is DMD; the disease is cancer.